severe cases
[대역어] 심한 사례
[용어속성] Patient
[용어속성] Patient
COVID-19: risk factors for severe cases of the Delta variant
Covid-19 : 델타 변형의 심각한 사례에 대한 위험 요소
Comparative Study
[키워드] 95% CI
age
Bilirubin
clinical feature
Clinical features
COVID-19
delta variant
Each
elevated
enrolled
greater
Guangzhou
Guangzhou, China
increase in
independent risk factor
independent risk factors
non-severe group
Older age
Patient
progression
regression analysis
risk
risk factor
Risk factors
Severe case
severe cases
severity
Spread
the SARS-CoV-2
total bilirubin
total bilirubin level
variant
were used
[DOI] 10.18632/aging.203655 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.18632/aging.203655 PMC 바로가기 [Article Type] Comparative Study
Multicellular spatial model of RNA virus replication and interferon responses reveals factors controlling plaque growth dynamics
Research Article
[키워드] acute respiratory syndrome
Analysis
antiviral response
Cell
Cell culture
coefficients
condition
coronavirus
COVID-19
cultures
cytokine
cytokine signaling
Cytokine storm
diffusion
drug candidates
early stage
epithelial
evaluated
evidenced
excessive inflammation
exhibit
experiment
Factor
flu
form
growth
H1N1 influenza
H3N2
help
highlight
immune
immune response
immunopathology
IMPROVE
in some
in vitro
include
induce
Infection
inflammatory condition
Inflammatory response
Influenza
inhibit
innate immune response
interferon
interferon response
interferon signaling
interferons
involved
JAK/STAT pathway
lesion
linear
local concentration
lung
lung cell
Lung epithelial cells
Lung infection
Lungs
manifestation
mechanism
molecular
multicellular
Occurrence
pandemic
Pandemics
parameter
pathway
performed
plaque
plaques
protective effect
public health
radial growth
Replication
respiratory
Respiratory disease
respiratory infection
responsible
reveal
RNA virus
RNA viruses
SARS-CoV-2
severe cases
severe inflammation
severity
Signaling
signaling molecule
Spanish
the disease
tissue
Treatment
Trigger
type I interferons
understanding
Variation
viral growth
Viral load
viral replication
virus
virus-infected cell
[DOI] 10.1371/journal.pcbi.1008874 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pcbi.1008874 PMC 바로가기 [Article Type] Research Article
Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients
Article
[키워드] acute respiratory distress
Admission
Algorithm
ARDS
Biomarker
Biomarkers
caused
Clinical severity
complement system
Coronavirus disease 2019
Course
COVID-19
COVID-19 patients
COVID-19 symptomatic patient
Critically ill patient
death
Disease progression
evaluated
facilitate
global pandemic
health care systems
healthy controls
hospital resources
Hospitalized
ICU
intensive care
management
marker
Mild
Mild symptom
moderate
molecular
multiple organ failure
outcome
Patient
prediction
receptor
risk
risk stratification in the emergency room
SARS-CoV-2
SARS-COV-2 infection
Sepsis
serum
severe cases
severe disease
severely ill patients
spread to
suPAR
syndrome
thrombotic complication
urokinase
with COVID-19
with mild disease
[DOI] 10.3390/jcm10214914 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm10214914 PMC 바로가기 [Article Type] Article
Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission
Microbiology
[키워드] acute respiratory syndrome
ADAR
analyzed
APOBEC
association
Asymptomatic
Beta
clinical
Clinical outcome
Complete
coronavirus
coronavirus 2
coronavirus disease
correlated
COVID-19
Critical
D614G
enzyme
Epidemic
expression
Frame
Frequency
Gamma
GISAID database
hotspot
mechanism
Mild
mild case
Mutation
mutation hotspots
mutations
occur
occurred
ORF1ab
outcome
pandemic
predict
Prevalence
Q57H
RdRP
respiratory
RNA-dependent RNA polymerase
SARS-CoV-2
SARS-CoV-2 sequence
severe cases
severe disease
shown
single-nucleotide
SNV
strain
Strains
symptomatic
the SARS-CoV-2
the SARS-CoV-2 genome
Treatment
understanding
variant
[DOI] 10.3389/fmicb.2021.753823 PMC 바로가기 [Article Type] Microbiology
[DOI] 10.3389/fmicb.2021.753823 PMC 바로가기 [Article Type] Microbiology
COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks
COVID-19는 다기관 공격자입니다: 후성 유전적 및 임상적 징후
Review
[키워드] ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alterations
chromatin
clinical
clinical manifestation
clinical phenotype
clinical phenotypes
Clinical significance
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
Cytokine storm
DNA methylation
driven by
environmental factors
Epigenetic
epigenetics
event
Genetic
highlight
histone
host genome
Infection
involved
management
MARK
mechanisms
multi-organ
occur
pro-inflammatory cytokines
progression
respiratory
respond
resulting
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe cases
severe COVID-19
survival
therapeutic
TMPRSS2
understanding
Viral
viral replication
virus
viruses
with COVID-19
[DOI] 10.3389/fimmu.2021.752380 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fimmu.2021.752380 PMC 바로가기 [Article Type] Review
Clinical Presentation of a COVID-19 Delta Variant Patient: Case Report and Literature Review
Internal Medicine
[키워드] acute respiratory distress
Admission
Antibiotics
ARDS
bilateral pneumonia
cause
clinical
clinical outcomes
coronavirus
cough
Course
COVID pneumonia
COVID-19
Critical care
Delta
delta variant
Diagnosis
diarrhea
difficulty breathing
Genetic variation
had no
high risk
hospital
hypoxic respiratory failure
ICU admission
ICU admissions
Immune escape
intensive care
Intubated
lab
literature
management
mechanical ventilation
mechanically ventilated
Mutation
over
pandemic
past medical history
patchy
Patient
Pneumonia
presentation
Prevent
Re-infection
Remdesivir
report
reported
review
SARS-CoV-2
severe cases
Shortness of breath
spike glycoprotein
sputum
Steroids
syndrome
the patient
Tocilizumab
transfer
treated
vaccination
Ventilation
with COVID-19
worsened
[DOI] 10.7759/cureus.18603 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.18603 PMC 바로가기 [Article Type] Internal Medicine
COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases
Case Report
[키워드] acute respiratory disease
Analysis
Case report
caused
Computed tomography
consolidation
coronavirus
Coronavirus disease 2019
COVID-19
discharged
disease
distal
distress
evaluate
Evidence
examined
FIVE
Foetal vascular underperfusion
gestation
Ground-glass opacities
histological
immunoreactivity
Inflammatory
late stage
lesion
lesions
lobular
Maternal vascular underperfusion
Mild
nasopharyngeal
Newborn
novel coronavirus SARS-CoV-2
outcome
pandemic
Particle
performed
placental
placental tissue
Pneumonia
Pregnancy
pregnant women
risk
SARS-CoV-2
SARS-CoV-2 transmission
severe cases
Structure
subsegmental
syndrome
the disease
thrombotic
Two patient
Ultrastructural analysis
Vascular
with COVID-19
women
[DOI] 10.1186/s13000-021-01148-6 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s13000-021-01148-6 PMC 바로가기 [Article Type] Case Report
Clinical, obstetrical and anaesthesia outcomes in pregnant women during the first COVID-19 surge in France: A prospective multicentre observational cohort study
Observational Study
[키워드] Admission
age
anaesthesia
Caesarean section
clinical
Cohort
cohort study
conducted
COVID-19
Critical care
Factor
First wave
form
France
Haemoglobin
hospitalisation
ICU
ICU admission rate
intensive care
invasive
Labour
morbidity
multicentre
nasal oxygen
non-invasive ventilation
Observational cohort study
Obstetric
occurred
outcome
oxygen saturation
oxygen supplementation
oxygen support
Patient
Positive test
Postpartum
Pregnancy
pregnant women
preterm delivery
Prevalence
proportion
receiving
Respiratory Support
resulting
retrospective
risk factor
RT-PCR testing
SARS-CoV-2
severe cases
SOFAresp
therapy
Ventilation
was performed
with COVID-19
women
[DOI] 10.1016/j.accpm.2021.100937 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.accpm.2021.100937 PMC 바로가기 [Article Type] Observational Study
Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey
Clinical Trial
[키워드] 95% CI
added
administration
age
Biorender.com
Cell
clinical
clinical experience
Clinical outcome
COVID-19
COVID-19 case
COVID-19 patient
COVID-19 patients
Critical
Critically ill
Cytokine storm
discharged
downregulate
Effect
elevated
evaluated
group
groups
ICU
immunomodulatory effects
IMPROVE
Intubated
intubated patient
intubation
Linear regression analysis
MSC
MSCs
organ
Oxygenation
parameter
pathophysiology
Patient
patients
patients hospitalized
phase
randomised
risk
Safe
SARS-CoV-2
severe cases
severe COVID-19
severe COVID-19 patient
severe COVID-19 patients
statistically significant
stem cell
Stem cell therapy.
survival
the cytokine storm
therapeutic
Therapeutic benefit
Therapeutic treatment
therapy
tissue
treated
Treatment
Turkey
UC-MSC
UC-MSCs
umbilical
[DOI] 10.1007/s12015-021-10214-x PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1007/s12015-021-10214-x PMC 바로가기 [Article Type] Clinical Trial